IPTACOPAN
Manner of administration:Oral
Restriction
Indication: Paroxysmal nocturnal haemoglobinuria (PNH)
Treatment phase: Initial treatment (new patient)
Restriction
Indication: Paroxysmal nocturnal haemoglobinuria (PNH)
Treatment phase: Return from PBS-subsidised eculizumab post pregnancy or from PBS-subsidised Complement
5 (C5) inhibitor for reasons other than post pregnancy
Restriction
Indication: Paroxysmal nocturnal haemoglobinuria (PNH)
Treatment phase: Continuing treatment
Restriction
Indication: Paroxysmal nocturnal haemoglobinuria (PNH)
Treatment phase: Transitioning from non-PBS to PBS-subsided treatment - Grandfather arrangements
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 56 | # of repeats: 5 | DPMQ: $38,820.15 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Fabhalta | |||||